| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.6M | — | -19.1% |
| Cost of Revenue | $3.0M | — | -7.3% |
| Gross Profit | $4.5M | — | -25.4% |
| R&D Expense | $3.7M | — | -50.9% |
| SG&A Expense | $5.6M | — | +7.2% |
| Operating Income | -$7.1M | — | +40.9% |
| Pre-tax Income | -$7.0M | — | +40.5% |
| Income Tax | $1K | — | -95.0% |
| Net Income | -$7.0M | — | +40.6% |
| EPS (Basic) | -$0.32 | — | +41.8% |
| EPS (Diluted) | -$0.32 | — | +41.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.8M | -10.2% | -0.9% |
| Short-term Investments | $1.1M | -62.4% | -91.0% |
| Accounts Receivable | $7.1M | +8.9% | +9.6% |
| Current Assets | $19.0M | -10.8% | -38.4% |
| Total Assets | $48.5M | -8.4% | -27.1% |
| Current Liabilities | $10.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.8M | — | +66.3% |
| Capital Expenditures | $44K | — | -20.0% |
| Investing Cash Flow | $1.8M | — | -50.0% |
| Financing Cash Flow | -$888K | — | +43.1% |
| Free Cash Flow | -$1.9M | — | +65.9% |
| -10.6% |
| Total Liabilities | $14.4M | +13.5% | -12.5% |
| Stockholders' Equity | $34.1M | -15.3% | -31.9% |